[Neonatal screening: dynamics and ethics]

G M W R de Wert1

  • 1Universiteit Maastricht, Faculteit der Geneeskunde, Postbus 6I6, 6200 MD Maastricht. g.dewert@ige.unimaas.nl

Insights

The Health Council of the Netherlands recommends screening newborns for 8 treatable conditions, emphasizing informed parental consent during pregnancy. Further discussion is needed on screening for untreatable conditions and carrier screening versus newborn screening.

Area of Science:

  • Public Health
  • Genetics
  • Pediatrics

Background:

  • A recent report from the Health Council of the Netherlands addresses neonatal screening.
  • The report recommends expanding newborn screening to include 8 treatable conditions.

Discussion:

  • The importance of comprehensive parental information, ideally provided during pregnancy, is highlighted.
  • Debate is ongoing regarding the inclusion of untreatable conditions in neonatal screening programs.
  • The comparative benefits of screening newborns versus screening prospective parents for carrier status require further examination.

Key Insights:

  • Neonatal screening can identify treatable conditions in newborns.
  • Informed parental consent is crucial for ethical screening practices.
  • Carrier screening offers an alternative approach to prevent the birth of affected children.

Outlook:

  • Future neonatal screening protocols may incorporate a wider range of conditions.
  • Continued dialogue is essential to optimize newborn screening strategies.
  • Integrating carrier screening into reproductive health services could be explored.